Skip to main content

MASTR Reporter update

Agilent Technologies is a strong and reliable player in molecular diagnostics. We provide your laboratory with a broad range of molecular Next-Generation Sequencing solutions, which guide you towards reliable results. Last year, Agilent launched the MASTR Reporter for the germline BRCA solutions. The MASTR Reporter is a variant analysis software, optimized for MASTR assays, that also allows you to monitor and trace the quality of your results and manage the entire workflow of your laboratory.

Today we are proud to announce the updated version of the MASTR Reporter. This new version includes the addition of a somatic pipeline, which means that BRCA MASTR Plus for somatic applications and Tumor Hotspot MASTR plus are now available on the MASTR Reporter. We have also added an additional germline application, CFTR MASTR, as well as some new features to ensure optimal analysis of your NGS results. These new features include an optional gene and variant filter to customize your output, as well as a link to variant annotation information from Agilent Alissa interpret.

What is MASTR Reporter?
MASTR Reporter updated features:
  • Optimized software for MASTR assays: simple, fast and reliable, a ‘transparent box’ (all information transparent and available for review).
  • Improved QC dashboard: integrated quality control to monitor the full workflow.
  • Variant or gene filtering option
  • A PCR stutter correction for homo/heteropolymer regions
  • A link to variant annotation information from Alissa Interpret
  • Metrics for traceability and audits.
  • Extensive support tools to help with validation in the laboratory.
MASTR Reporter available applications:

For Research Use Only. Not in use for diagnostic procedures.

CFTR MASTR v2

Cystic Fibrosis

Not for sale in Europe

BRCA Hereditary Cancer MASTR Plus

Breast & Ovarian

BRCA MASTR Plus

Breast, Ovarian and

other Cancers

Not for sale in Europe, US & Canada

Tumor Hotspot MASTR Plus

Gastrointestinal,

Glioblastomas,

Colon, Lung,

Breast, Ovarian,

Endometrial and

other Cancers

For In Vitro Diagnostic Use. (Only available in Europe)

BRCA MASTR Dx

Breast, Ovarian and

other Cancers

BRCA MASTR Plus Dx

Breast, Ovarian and

other Cancers

CFTR MASTR Dx

Cystic Fibrosis


Alissa Interpret is a USA Class I Exempt Medical Device, Europe CE IVD, Canada and Australia Class I IVD Device